LONDON, June 27, 2014 /PRNewswire/ --
- Editor Note: For more information about this release, please scroll to bottom.
Today, Earnings Review released its analysts' notes regarding AstraZeneca Plc (LON: AZN), SABMiller Plc (LON: SAB), Lloyds Banking Group Plc (LON: LLOY), Rio Tinto Plc (LON: RIO) and Daejan Holdings Plc (LON: DJAN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/4215-100free.
AstraZeneca Plc Analyst Notes
On June 12, 2014, AstraZeneca Plc (AstraZeneca) announced a global license agreement with Synairgen Plc, an AIM-listed UK company focusing on respiratory diseases, for SNG001, a novel, inhaled interferon beta (IFN-beta) in clinical development for treating respiratory tract viral infections in patients with severe asthma. AstraZeneca informed that SNG001 supports the immune system by correcting a deficiency which makes patients vulnerable to respiratory tract viral infections. Under the terms of the exclusive licence agreement, the Company will pay Synairgen a $7.25 million up-front fee and potential development, regulatory and commercial milestones of up to $225 million. In addition, AstraZeneca will pay tiered royalties ranging from single-digit up to mid-teens on commercial sales and will also be responsible for future development costs. The full analyst notes on AstraZeneca are available to download free of charge at:
SABMiller Plc Analyst Notes
According to the financial calendar available at the official website of SABMiller Plc (SABMiller), the Company will issue its Q1 FY 2015 Trading Statement on July 24, 2014. The 2014 Annual General Meeting is also scheduled for the same day. SABMiller had recently touched its 52-week high amid speculations of merger talks with a major European beer company, according to a Reuters report dated June 10, 2014. According to a previously issued Trading Update, the Company is also reviewing its holding in Tsogo Sun Holdings Limited as it as SABMiller does not consider it to be core to its beverage operations. SABMiller, on May 22, 2014, released its preliminary results for FY 2014, showing a decline of 0.8% YoY in Group Net Producer Revenue at $26.7 billion. The full analyst notes on SABMiller are available to download free of charge at:
Lloyds Banking Group Plc Analyst Notes
On June 24, 2014, Lloyds Banking Group Plc (Lloyds Banking Group) announced initiative to help improve the lack of digital skills in the UK's North West region which, according to a recent research, is still lagging when compared to the rest of the UK. As part of the initiative, Halifax and Lloyds Bank, part of Lloyds Banking Group and a proud founder of Go ON UK - the digital skills charity - have pledged to sign up at least 2,000 staff members ("Digital Champions") to help bridge this gap. The initiative titled "Go ON North West" aims at boosting the digital skills of people, small businesses and charities by 25% in twelve months, said the Company. According to Llyods Banking Group, the Digital Champions across 207 Halifax and Lloyds Bank branches in the North West will provide practical advice to customers, businesses and charities to help them understand the internet. The full analyst notes on Lloyds Banking Group are available to download free of charge at:
Rio Tinto Plc Analyst Notes
On June 2, 2014, Rio Tinto Plc (Rio Tinto) announced that it has completed the sale of its 50.1% interest in the Clermont Joint Venture to GS Coal Pty Ltd, a company jointly-owned by Glencore and Sumitomo Corporation, for US$1.015 billion. Under the terms of the sale, Glencore has taken over management of Clermont Mine, which produces thermal coal in central Queensland. Rio Tinto stated that it remains committed to a long-term future in the Australian coal industry, where its mines provide work for more than 5,000 people in Queensland and New South Wales. The full analyst notes on Rio Tinto are available to download free of charge at:
Daejan Holdings Plc Analyst Notes
On June 24, 2014, Daejan Holdings Plc's (Daejan) stock declined for a third consecutive session and ended lower by 1.24% at £4,765.00. The Company's stock opened at £4,823.00, and fluctuated within the range of £4,723.99 - £4,823.00 during the session. According to a Reuters report dated June 24, 2014, UK stocks came under pressure amidst signs of economic weakness in the region and tense situations in Iraq. The report suggested that investors turned cautious after Bank of England Governor Mark Carney's comments on interest rates. Meanwhile, the stock of Daejan has weakened by 0.27% in the last one month. The full analyst notes on Daejan are available to download free of charge at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] earnings-review.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] earnings-review.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] earnings-review.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Earnings Review